Yok-Ai Que Selected Research

Lithostathine

1/2022	Role of Pancreatic Stone Protein as an Early Biomarker for Risk Stratification of Acute Pancreatitis.
1/2021	Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study.
1/2021	Accuracy of pancreatic stone protein for the diagnosis of infection in hospitalized adults: a systematic review and individual patient level meta-analysis.
1/2019	Measurement of pancreatic stone protein in the identification and management of sepsis.
9/2015	Prognostication of Mortality in Critically Ill Patients With Severe Infections.
7/2012	Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yok-Ai Que Research Topics

Disease

25	Infections 01/2022 - 05/2005
10	Burns 06/2021 - 02/2012
9	Endocarditis 01/2022 - 05/2005
8	Wounds and Injuries (Trauma) 06/2021 - 02/2012
7	Sepsis (Septicemia) 09/2021 - 07/2012
5	Pneumonia (Pneumonitis) 01/2022 - 04/2015
4	Critical Illness (Critically Ill) 01/2022 - 08/2015
3	Body Weight (Weight, Body) 01/2022 - 01/2018
3	Wound Infection (Wound Infections) 06/2021 - 02/2012
3	Bacterial Infections (Bacterial Infection) 03/2021 - 02/2012
2	COVID-19 01/2022 - 01/2021
2	Ventilator-Associated Pneumonia 09/2021 - 11/2019
2	Septic Shock (Toxic Shock Syndrome) 04/2015 - 07/2012
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 01/2022
1	Pancreatitis 01/2022
1	Meningitis 01/2022
1	Staphylococcal Infections 01/2022
1	Neoplasms (Cancer) 12/2021
1	Contact Dermatitis (Eczema, Contact) 12/2020
1	Pseudomonas Infections 01/2017
1	Cross Infection (Nosocomial Infection) 05/2016
1	Systemic candidiasis 04/2015
1	Acute Kidney Injury (Acute Renal Failure) 12/2013
1	Bacteremia 03/2013
1	Coinfection 01/2013
1	Inflammation (Inflammations) 02/2012

Drug/Important Bio-Agent (IBA)

12	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 06/2011
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2012
6	LithostathineIBA 01/2022 - 07/2012
5	Pharmaceutical PreparationsIBA 12/2021 - 01/2013
5	C-Reactive ProteinIBA 01/2021 - 07/2012
5	Fibronectins (Fibronectin)IBA 03/2013 - 05/2005
4	ProcalcitoninIBA 01/2021 - 07/2012
3	CreatinineIBA 01/2022 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2012
3	Fibrinogen (Factor I)FDA Link 03/2013 - 05/2005
3	bacterial fibronectin-binding proteinsIBA 11/2011 - 05/2005
2	Vancomycin FDA LinkGeneric 01/2022 - 01/2022
2	ChlorhexidineIBA 12/2020 - 01/2019
2	Carrier Proteins (Binding Protein)IBA 03/2009 - 04/2007
2	factor AIBA 04/2007 - 05/2005
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	Phosphates (Orthophosphate)IBA 01/2022
1	endolysinIBA 01/2022
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2022
1	Floxacillin (Flucloxacillin)IBA 01/2022
1	Cefepime (Maxipime)FDA LinkGeneric 12/2021
1	Chimeric Antigen ReceptorsIBA 12/2021
1	Tazobactam FDA LinkGeneric 10/2021
1	Piperacillin FDA LinkGeneric 10/2021
1	Therapeutic UsesIBA 09/2021
1	Daptomycin FDA Link 09/2021
1	CoagulaseIBA 09/2021
1	Dendrimers (Dendrons)IBA 06/2021
1	Antimicrobial PeptidesIBA 06/2021
1	prednylidene (Pred)IBA 01/2021
1	TeicoplaninIBA 11/2019
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2019
1	IronIBA 01/2018
1	pyoverdinIBA 01/2018
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2018
1	Virulence Factors (Pathogenicity Factors)IBA 03/2016
1	Biological ProductsIBA 03/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	CytokinesIBA 01/2016
1	Ticlopidine (Ticlid)FDA LinkGeneric 11/2015
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2015
1	Meropenem (Merrem)FDA LinkGeneric 08/2015
1	Carbapenems (Carbapenem Antibiotics)IBA 08/2015
1	Imipenem Drug Combination Cilastatin (Primaxin)FDA Link 08/2015
1	VaccinesIBA 07/2015
1	Terbinafine (Lamisil)FDA LinkGeneric 03/2015
1	Voriconazole (Vfend)FDA LinkGeneric 03/2015
1	AntithrombinsIBA 01/2015
1	Interleukin-6 (Interleukin 6)IBA 07/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2012
1	Interleukin-1beta (Interleukin 1 beta)IBA 07/2012
1	Interleukin-8 (Interleukin 8)IBA 07/2012
1	EnzymesIBA 02/2012
1	Glutathione Transferase (Glutathione S-Transferase)IBA 02/2012
1	TransferasesIBA 02/2012
1	leukotriene-C4 synthaseIBA 02/2012
1	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 02/2012
1	acetophenoneIBA 08/2011
1	Peptidoglycan (Murein)IBA 08/2008
1	ElastinIBA 08/2008

Therapy/Procedure

9	Phage Therapy 01/2022 - 04/2015
6	Therapeutics 09/2021 - 03/2015
4	Critical Care (Surgical Intensive Care) 01/2022 - 07/2012
3	Extracorporeal Membrane Oxygenation 01/2022 - 10/2021
3	Catheters 09/2021 - 05/2016
1	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022
1	Intraperitoneal Injections 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2021
1	Vascular Access Devices (Arterial Line) 01/2019
1	Central Venous Catheters 01/2019
1	Continuous Renal Replacement Therapy 12/2013